Keyword: Third Rock Ventures
Relay Therapeutics reeled in a $400 million round to boost its platform technology and discovery efforts, build its pipeline and get into the clinic.
The appointment means Gentile will commit full time to the autophagy startup he helped get off the ground.
Janssen Research & Development’s global head of discovery, Dashyant Dhanak, Ph.D., is joining Incyte to serve as its chief scientific officer.
Sean Harper to help run $320M VC fund; Agios crowns Jackie Fouse as CEO; and hospital-backed Civica Rx nabs Amgen vet as CEO.
The appointment puts Keswani in charge of overseeing Rheos’ pipeline of immunometabolism assets.
Gilead CMO quits six months after taking job; Allergan taps Pfizer vet as CMO; and Novartis recruits Siemens ethics chief as it reels from scandal.
Third Rock Ventures has named Steven Kafka, former president and chief operating officer of Foundation Medicine, as a new venture partner.
Ambys Medicines will develop cell and gene therapies, as well as drugs, for chronic liver diseases.
Decibel Therapeutics raised $55 million in a series C round and named Vir Biotechnology CEO George Scangos as chair of its board of directors.
Armed with $65 million in series A funding, Celsius will sequence defined patient samples to identify the individual cells responsible for disease.